Literature DB >> 16959222

Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells.

Romain Blasius1, Simone Reuter, Estelle Henry, Mario Dicato, Marc Diederich.   

Abstract

Signal transducers and activators of transcription (STATs) play important roles in numerous cellular events as for example differentiation, inflammation or immune response. Furthermore, constitutive STAT activation can be observed in a high number of tumors. In our hands, curcumin treatment induced a decrease of nuclear STAT3, -5a and -5b, without affecting neither STAT1, nor the phosphorylation state of STAT1, -3 or -5 in the K562 cell line. Most interestingly, the decrease of nuclear STAT5a and -5b after curcumin treatment was accompanied by an increase of truncated STAT5 isoforms, indicating that curcumin is able to induce the cleavage of STAT5 into its dominant negative variants lacking the STAT5 C-terminal region. Interferon (IFN)-beta and -gamma treatment induced IFN-stimulated responsive element (ISRE) transcriptional activity, which was efficiently inhibited by curcumin pre-treatment. In parallel, IFN-gamma treatment induced an increase of the amount of nuclear STAT1 and -3, as well as their phosphorylated isoforms. Again, curcumin pre-treatment inhibited these increases. Finally, curcumin treatment inhibited Jak2 mRNA expression as well as cyclin D1 and v-src gene expression in K562 chronic leukaemia cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959222     DOI: 10.1016/j.bcp.2006.07.029

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  21 in total

Review 1.  Cancer cell signaling pathways targeted by spice-derived nutraceuticals.

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Bharat B Aggarwal
Journal:  Nutr Cancer       Date:  2011-12-09       Impact factor: 2.900

2.  Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network.

Authors:  Anne Trécul; Franck Morceau; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2012-01-25       Impact factor: 5.523

3.  Curcumin enhances cisplatin sensitivity by suppressing NADPH oxidase 5 expression in human epithelial cancer.

Authors:  Siqi Chen; Wei Gao; Min-Juan Zhang; Jimmy Yu-Wai Chan; Thian-Sze Wong
Journal:  Oncol Lett       Date:  2019-06-14       Impact factor: 2.967

Review 4.  Cancer and diet: How are they related?

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Afsaneh Lavasanifar; Bharat B Aggarwal
Journal:  Free Radic Res       Date:  2011-06-09

5.  Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression.

Authors:  Jin Chen; Feng-Ling Wang; Wei-Dong Chen
Journal:  Mol Biol Rep       Date:  2014-03-07       Impact factor: 2.316

Review 6.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

Review 7.  Molecular targets of curcumin for cancer therapy: an updated review.

Authors:  Pandima Devi Kasi; Rajavel Tamilselvam; Krystyna Skalicka-Woźniak; Seyed Fazel Nabavi; Maria Daglia; Anupam Bishayee; Hamidreza Pazoki-Toroudi; Seyed Mohammad Nabavi
Journal:  Tumour Biol       Date:  2016-07-28

8.  Cancer-linked targets modulated by curcumin.

Authors:  Noor Hasima; Bharat B Aggarwal
Journal:  Int J Biochem Mol Biol       Date:  2012-12-24

9.  Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines.

Authors:  Matthew A Bill; Courtney Bakan; Don M Benson; James Fuchs; Gregory Young; Gregory B Lesinski
Journal:  Mol Cancer Ther       Date:  2009-09-01       Impact factor: 6.261

10.  Synthetic curcumin analog: inhibiting the invasion, angiogenesis, and metastasis in human laryngeal carcinoma cells via NF-kB pathway.

Authors:  Kumaravel Mohankumar; Arul Prakash Francis; Sankar Pajaniradje; Rukkumani Rajagopalan
Journal:  Mol Biol Rep       Date:  2021-08-05       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.